Sofosbuvir Velpatasvir Buy Online | Sunny Pharma®

sofosbuvir velpatasvir

Sofosbuvir Velpatasvir Buy Online

Epclusa (sofosbuvir velpatasvir/ generic Epclusa) is a prescription medication to treat chronic hepatitis C.

HCV genotypes that can be treated with sofosbuvir velpatasvir are 1, 2, 3, 4, 5 or 6.

You take one tablet a day for 84 days to clear the hepatitis C virus.

Hepatitis C patients that complete the 12 week treatment, have a cure rate of 94% to 99%.

Sofosbuvir velpatasvir is actually generic Epclusa distributed by Asegua Therapeutics, a subsidiary of Gilead Sciences.

This combination hepatitis C treatment goes by the brand name Epclusa in US and most European countries.

Tablet price of sofosbuvir and velpatasvir 400mg 100mg price in India is about $8 a tablet.

A lot less affordable than the US, where it costs $1125 a tablet.

The most popular brand name in the US is Epclusa.

In India, sofosbuvir velpatasvir/Epclusa is called Velpanat, Velasof, MyHep ALL, Resof Total and many other brand names exist.

Epclusa was first introduced by Gilead Sciences in the United States in 2016 and the same year it was acknowledged by the World Health Organization as an Essential Medicine to treat hepatitis C.

Sofosbuvir-Velpatasvir
Sofosbuvir-Velpatasvir

Epclusa is a one a day tablet for chronic hepatitis C treatment for 84 days or 12 weeks.

It has shown to be effective for more than 93% to 99% of patients.

Sometimes Epclusa is taken with weight based ribavirin for hep C patients with cirrhosis, de-compensated liver and HIV co-infection.

1. Biological Role of Epclusa Sofosbuvir Velpatasvir

epclusa price in India

Velpatasvir blocks N5SA protein that replicates the hepatitis C virus.

While sofosbuvir in conjunction blocks the N5SB protein replicating mechanism.

2. Contraindications of Epclusa

epclusa cost in India

Velpatasvir and sofosbuvir combination effectiveness is reduced with liver enzymes CYP2B6, CYP2C8 or CYP3A4, or with P-glycoprotein.

At the time of writing this, no other contraindications were documented.

3. Pregnancy and Breastfeeding


Not enough data is available to suggest safe use of Epclusa in pregnant women and child breastfeeding.

4. Common Side Effects of Epclusa

A little more than 10% of hepatitis C patients experience mild headache, nausea, sleeping difficulty (insomnia) and fatigue.

It is also important to note, a placebo produced approximately the same results.

5. Cost of Epclusa (sofosbuvir velpatasvir buy online)

Three bottles of Epclusa, 12 weeks treatment, 84 tablets cost $78,078 in the US.

Epclusa cost in India is about $777  for 12 weeks treatment, you can order here.

Generic Epclusa is goes by the chemical name sofosbuvir velpatasvir.

Gilead Sciences gave the patent to many Indian pharmaceuticals to manufacture and distribute in poor countries, while they collect royalties on all hep C meds sold.

6. Treatment Options

Sofosbuvir-Velpatasvir
Sofosbuvir 400mg -Velpatasvir 90mg

Previously, 75% to 85% of hepatitis C patients were not approved by insurers for sofosbuvir and velpatasvir or Epclusa.

This was due to the cost of $78,078 for 12 weeks treatment.

Usually patients have to be in critical condition, de-compensated liver, cirrhosis and or a firbroscan of 3 or lower.

Many patients do not want to wait til the end because sometimes it can be too late for treatment.

Unfortunately we have come across too many preventable cases like this.

7. Ordering Your Epclusa or Sofosbuvir Velpatasvir buy online

Good news is you have treatment options, Epclusa cost in India is affordable and you can order it online, right here.

Sunny Pharma will deliver Harvoni, Sovaldi, Epclusa and Daklinza to your front door in about 10 to 12 days.

8. What is sofosbuvir/velpatasvir/voxilaprevir?

Sofosbuvir/velpatsvir/voxilaprevir (Vosevi) is a drug that is used to treat hepatitis C.

The combination of sofosbuvir 400mg, voxilaprevir 100mg and velpatasvir 100mg.

The combination of medicines was developed by Gilead Sciences and is marketed as Vosevi.

Vosevi is once a day oral tablet for 84 days to treat hepatitis C virus genotypes 1, 2, 3, 4, 5 or 6.